SWOG 1900A:A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)

Start Date: December 10, 2018

IRB Number: pending

Condition/Disease: Cancer - Lung

Principal Investigator: Ding Wang, MD

Purpose of Research: CANCER, LUNG, LUNG CANCER, STAGE 4, NON SMALL CELL, NSCLC

Status: Open

Phone: (313) 916-1784

Filter Results